Faithward Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Faithward Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-676	Closed	-$91.2K	–	267
2023 Q4	$91.2K	Hold	676	–	–	0.02%	180
2023 Q3	$78K	Sell	676 -120	-15%	-$15.3K	0.02%	175
2023 Q2	$102K	Hold	796	–	–	0.02%	177
2023 Q1	$104K	Sell	796 -90	-10%	-$11.8K	0.02%	201
2022 Q4	$116K	Sell	886 -105	-11%	-$13.6K	0.03%	155
2022 Q3	$116K	Sell	991 -14	-1%	-$1.74K	0.03%	143
2022 Q2	$118K	Hold	1,005	–	–	0.03%	158
2022 Q1	$131K	Sell	1,005 -95	-9%	-$12.4K	0.03%	170
2021 Q4	$168K	Sell	1,100 -100	-8%	-$15.5K	0.03%	167
2021 Q3	$194K	Sell	1,200 -225	-16%	-$37.9K	0.04%	176
2021 Q2	$233K	Sell	1,425 -150	-10%	-$23.1K	0.05%	152
2021 Q1	$237K	Buy	+1,575	New	+$250K	0.05%	147
2020 Q4	–	Sell	-1,985	Closed	-$269K	–	160
2020 Q3	$269K	Hold	1,985	–	–	0.07%	114
2020 Q2	$271K	Sell	1,985 -2,243	-53%	-$286K	0.07%	117
2020 Q1	$456K	Sell	4,228 -510	-11%	-$58.7K	0.13%	105
2019 Q4	$571K	Hold	4,738	–	–	0.13%	87
2019 Q3	$471K	Buy	+4,738	New	+$496K	0.1%	65

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Faithward Advisors's IBB Position: Q1 2024 in Review

Faithward Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 676 shares — an estimated $91.2K sold.

Faithward Advisors first reported a position in IBB in Q3 2019 and held it in 17 quarters. The position peaked at $571K in Q4 2019. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

Faithward Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
Faithward Advisors sold 676 iShares Biotechnology ETF shares in Q1 2024, an estimated $91.2K.
Faithward Advisors first reported a position in iShares Biotechnology ETF in Q3 2019 and held it in 17 quarters.
Faithward Advisors's iShares Biotechnology ETF position peaked at $571K in Q4 2019.
899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Faithward Advisors's 13F filing for Q1 2024, filed 15 May 2024.